Chronic Obstructive Pulmonary Disease
Conditions
Keywords
Chronic obstructive pulmonary disease
Brief summary
Transcutaneous electrical muscle stimulation (TCEMS) is well established intervention for rehabilitation of clinically stable patients with chronic obstructive pulmonary disease. The investigators have conceived this study to test whether TCEMS is feasible and tolerated by patients experiencing severe physical and psychical challenge of acutely exacerbated COPD.
Interventions
On the first hospitalization day patients received lower extremity TCEMS. We used GymnaUniphy device (GymnaUniphy N.V., 2004, 3740 Bilzen, Belgium) with four surface patch electrodes applied over each lower extremity quadriceps muscle. Patients were in the supine position and were advised to relax during sessions. A prespecified program for lower extremity strength training in sessions of 25 minutes, twice a day (first training in the morning, second in the afternoon, with minimal time difference of 6 hours) was performed six days per week during the hospitalization.
Sponsors
Study design
Eligibility
Inclusion criteria
* chronic obstructive pulmonary disease GOLD stage III or IV * acute exacerbation of the disease
Exclusion criteria
* contraindications for transcutaneous electrical muscle stimulation
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Scores on the feasibility scale | 10 days (avarage time from admission to discharge) | Patients will be followed from admission until discharge |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Scores on the patient satisfaction scale | 10 days (avarage time from admission to discharge) | Patients will be followed from admission until discharge |
| Number of patients with adverse events as a measure of Safety and tolerability | 10 days (avarage time from admission to discharge) | Patients will be followed from admission until discharge |
| Health related quality of life on the St. George respiratory questionnaire | 10 days (avarage time from admission to discharge) | Patients will be followed from admission until discharge |
| Dyspnea on the MRC dyspnea scale | 10 days (avarage time from admission to discharge) | Patients will be followed from admission until discharge |
| Patient symptom scores on the Functional assessment of chronic illness therapy questionaire | 10 days (avarage time from admission to discharge) | Patients will be followed from admission until discharge |
Countries
Slovenia